Protalix BioTherapeutics
PLX
#8773
Rank
โ‚น14.82 B
Marketcap
โ‚น184.34
Share price
-0.97%
Change (1 day)
-4.08%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.81. In 2024 the company made an earnings per share (EPS) of โ‚น3.61 a decrease over its 2023 EPS that were of โ‚น10.84.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-51.72%
2024โ‚น3.61-66.67%
2023โ‚น10.84-138.71%
2022-โ‚น28.01-50%
2021-โ‚น56.02181.82%
2020-โ‚น19.88-82.11%
2019-โ‚น111.14-31.67%
2018-โ‚น162.65-72.31%
2017-โ‚น587.35124.14%
2016-โ‚น262.05-147.54%
2015โ‚น551.21-290.63%
2014-โ‚น289.166.67%
2013-โ‚น271.08130.77%
2012-โ‚น117.47-69.77%
2011-โ‚น388.5519.44%
2010-โ‚น325.30-12.2%
2009-โ‚น370.4836.67%
2008-โ‚น271.08-37.5%
2007-โ‚น433.7450%
2006-โ‚น289.163.23%
2005-โ‚น280.12138.46%
2004-โ‚น117.47-74%
2003-โ‚น451.81-0%
2002-โ‚น451.81-50%
2001-โ‚น903.62233.33%
2000-โ‚น271.08-84.21%
1999-โ‚น1,717-24%
1998-โ‚น2,259-600%
1997โ‚น451.81-16.67%
1996โ‚น542.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-โ‚น9.94-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น389.46 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น155.42 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.93 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel